FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386376892> ?p ?o ?g. }

• W4386376892 endingPage "107385" @default.
• W4386376892 startingPage "107385" @default.
• W4386376892 abstract "Mantle cell lymphoma (MCL) is a heterogeneous subtype of non-Hodgkin lymphoma that has been historically associated with poor 5-year overall survival rates, especially for aggressive variants. Traditional cytotoxic chemotherapy had been a mainstay of therapy for relapsed/refractory (R/R) MCL for many years until the advent of molecularly targeted therapies and cell-based approaches. However, a significant concern is the lack of definitive consensus guidelines for management of R/R MCL. The managerial conundrum likely stems from the absence of head-to-head comparisons of novel therapies, with conclusions drawn from cross-trial comparisons. In this evidence-based review, we discuss the current therapeutic options for R/R MCL, including the most recent data from the BRUIN study that led to the approval of the first-in-class non-covalent reversible Bruton’s tyrosine kinase (BTK) inhibitor pirtobrutinib in 2023, as well as the recent removal of ibrutinib from the market. We discuss outlooks for targeted therapy and tolerability considerations for novel agents, including unique considerations for the elderly population. We highlight emerging data that support the curative potential of chimeric antigen receptor-T (CAR-T) therapy from ZUMA-2, relative to other promising investigational agents in the pipeline, including glofitamab, epcoritamab, and zilovertamab vedotin. We summarize management recommendations based upon the most rigorous clinical evidence to date." @default.
• W4386376892 created "2023-09-02" @default.
• W4386376892 creator A5010728878 @default.
• W4386376892 creator A5040438640 @default.
• W4386376892 creator A5052376251 @default.
• W4386376892 date "2023-11-01" @default.
• W4386376892 modified "2023-10-16" @default.
• W4386376892 title "The Shifting Therapeutic Paradigm for Relapsed/Refractory Mantle Cell Lymphoma" @default.
• W4386376892 cites W2028681024 @default.
• W4386376892 cites W2032482627 @default.
• W4386376892 cites W2075875145 @default.
• W4386376892 cites W2093055119 @default.
• W4386376892 cites W2095669071 @default.
• W4386376892 cites W2112023756 @default.
• W4386376892 cites W2154066874 @default.
• W4386376892 cites W2171771895 @default.
• W4386376892 cites W2190884983 @default.
• W4386376892 cites W2263116683 @default.
• W4386376892 cites W2316021978 @default.
• W4386376892 cites W2569849048 @default.
• W4386376892 cites W2602369513 @default.
• W4386376892 cites W2748428998 @default.
• W4386376892 cites W2774522106 @default.
• W4386376892 cites W2800076358 @default.
• W4386376892 cites W2900472144 @default.
• W4386376892 cites W2917211451 @default.
• W4386376892 cites W2964310707 @default.
• W4386376892 cites W2977030866 @default.
• W4386376892 cites W2984031213 @default.
• W4386376892 cites W2985675201 @default.
• W4386376892 cites W3014583893 @default.
• W4386376892 cites W3097451869 @default.
• W4386376892 cites W3134524629 @default.
• W4386376892 cites W3151974300 @default.
• W4386376892 cites W3171882656 @default.
• W4386376892 cites W3176433809 @default.
• W4386376892 cites W3209585109 @default.
• W4386376892 cites W3210991186 @default.
• W4386376892 cites W3215937618 @default.
• W4386376892 cites W4220900334 @default.
• W4386376892 cites W4221068958 @default.
• W4386376892 cites W4281625438 @default.
• W4386376892 cites W4281650669 @default.
• W4386376892 cites W4281687647 @default.
• W4386376892 cites W4289527770 @default.
• W4386376892 cites W4296468337 @default.
• W4386376892 cites W4319457643 @default.
• W4386376892 cites W4366817498 @default.
• W4386376892 cites W4376636920 @default.
• W4386376892 cites W4385220271 @default.
• W4386376892 doi "https://doi.org/10.1016/j.leukres.2023.107385" @default.
• W4386376892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37672954" @default.
• W4386376892 hasPublicationYear "2023" @default.
• W4386376892 type Work @default.
• W4386376892 citedByCount "0" @default.
• W4386376892 crossrefType "journal-article" @default.
• W4386376892 hasAuthorship W4386376892A5010728878 @default.
• W4386376892 hasAuthorship W4386376892A5040438640 @default.
• W4386376892 hasAuthorship W4386376892A5052376251 @default.
• W4386376892 hasConcept C121608353 @default.
• W4386376892 hasConcept C126322002 @default.
• W4386376892 hasConcept C143998085 @default.
• W4386376892 hasConcept C197934379 @default.
• W4386376892 hasConcept C2777525834 @default.
• W4386376892 hasConcept C2777701055 @default.
• W4386376892 hasConcept C2777938653 @default.
• W4386376892 hasConcept C2778191690 @default.
• W4386376892 hasConcept C2778375690 @default.
• W4386376892 hasConcept C2778461978 @default.
• W4386376892 hasConcept C2779338263 @default.
• W4386376892 hasConcept C2779878957 @default.
• W4386376892 hasConcept C2781230642 @default.
• W4386376892 hasConcept C2908647359 @default.
• W4386376892 hasConcept C2992779791 @default.
• W4386376892 hasConcept C3875195 @default.
• W4386376892 hasConcept C535046627 @default.
• W4386376892 hasConcept C71924100 @default.
• W4386376892 hasConcept C99454951 @default.
• W4386376892 hasConceptScore W4386376892C121608353 @default.
• W4386376892 hasConceptScore W4386376892C126322002 @default.
• W4386376892 hasConceptScore W4386376892C143998085 @default.
• W4386376892 hasConceptScore W4386376892C197934379 @default.
• W4386376892 hasConceptScore W4386376892C2777525834 @default.
• W4386376892 hasConceptScore W4386376892C2777701055 @default.
• W4386376892 hasConceptScore W4386376892C2777938653 @default.
• W4386376892 hasConceptScore W4386376892C2778191690 @default.
• W4386376892 hasConceptScore W4386376892C2778375690 @default.
• W4386376892 hasConceptScore W4386376892C2778461978 @default.
• W4386376892 hasConceptScore W4386376892C2779338263 @default.
• W4386376892 hasConceptScore W4386376892C2779878957 @default.
• W4386376892 hasConceptScore W4386376892C2781230642 @default.
• W4386376892 hasConceptScore W4386376892C2908647359 @default.
• W4386376892 hasConceptScore W4386376892C2992779791 @default.
• W4386376892 hasConceptScore W4386376892C3875195 @default.
• W4386376892 hasConceptScore W4386376892C535046627 @default.
• W4386376892 hasConceptScore W4386376892C71924100 @default.
• W4386376892 hasConceptScore W4386376892C99454951 @default.
• W4386376892 hasFunder F4320310588 @default.

• next